State
20,322 recalls have nationwide distribution and so reach Wisconsin. 0 additional recalls listed Wisconsin specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect Wisconsin consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Homeocare Laboratories is recalling Arnica 7 Cream due to manufacturing standards deviations. The recall affects 2,376 bottles with lot number 2446.
StellaLife VEGA Oral Care Spray is being recalled for manufacturing deviations. The product was distributed nationwide; consumers should discontinue use of affected lots.
Homeocare Laboratories is recalling Babelyn Diarrhea Drops due to manufacturing control (cGMP) deviations. The voluntary recall affects 5,957 bottles distributed nationwide.
Volvo Trucks is recalling 2020-2023 VNR Electric vehicles equipped with Adaptive Cruise Control that can trigger aggressive braking under light load conditions, risking rear axle skidding and loss of vehicle control.
Subaru is recalling certain 2023 Ascent vehicles equipped with 20-inch wheels due to potential tire bead damage during manufacturing. The defect may cause sudden air pressure loss and increase crash risk.
Grand Design is recalling 139 units of 2023 Imagine travel trailers. The Federal Certification Label incorrectly states tire size and inflation pressure, which may cause premature tire wear or blowout, increasing crash risk.
Harley-Davidson is recalling 2019-2021 Sportster motorcycles and replacement headlight assemblies because the glass bulb may fail, causing loss of both high and low beams and increasing crash risk.
Certain 2021 Porsche Macan models have improperly tightened screw connections on shock absorbers, which could compromise braking and vehicle control. Porsche will repair the connections free of charge.
Kia is recalling 2021-2023 K5 vehicles due to potentially incorrect installation of side curtain air bags that could prevent proper deployment in a crash.
CaTeam is recalling about 700 Canvas Baby Hammock Swings sold online from November 2022 through January 2023 because they violate the Safe Sleep for Babies Act. The inclined design poses a suffocation risk to infants.
Bose Corporation is recalling select bass modules manufactured before April 2006 because electrical components can fail and cause fires. The firm has received 21 reports of ignition or melting worldwide, with three resulting in property damage.
Victrola is recalling about 5,700 Wood Metropolitan Bluetooth Record Players because they can overheat and catch fire. The company has received six reports of overheating or fire, including one minor injury and one report of minor property damage.
H-E-B is recalling about 1,400 Haven & Key Leather Woven Chairs because the backrest and legs can crack and break off when someone is seated, creating a fall hazard. The firm has received 11 reports of cracking or breaking, with no injuries reported.
Medtronic implantable cardioverter defibrillators (CRT-D) may deliver reduced or no energy during high-voltage therapy due to manufacturing defect in the feedthrough component. FDA Class I recall affects 182 units.
Medtronic's ICD COBALT defibrillators may fail to deliver critical therapy due to a manufacturing defect in a power delivery component. Patients should contact their physician to determine if affected.
Medtronic is recalling 664 implantable cardioverter defibrillators due to a rare potential for reduced or no energy output during high-voltage therapy. The defect could prevent critical defibrillation therapy when needed.
Medtronic's MIRRO MRI implantable cardioverter defibrillators with a specific glassed feedthrough may rarely fail to deliver adequate energy output during high-voltage therapy, affecting approximately 2,831 units distributed worldwide.
Medtronic implantable cardioverter defibrillators may fail to deliver critical therapy due to a feedthrough defect. The defect can cause reduced or absent energy output during high-voltage therapy in 8,602 affected units distributed worldwide.
Certain implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators may fail to deliver adequate energy during high-voltage therapy due to a specific feedthrough defect. Medtronic is recalling 1,132 affected units.
Certain Medtronic implantable cardioverter defibrillators with a specific feedthrough may produce reduced or no energy output during high voltage therapy. The rare defect affects 16 units distributed nationwide.
Medtronic is recalling certain implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) with specific glassed feedthroughs that may deliver reduced or no energy output during high voltage therapy.
Medtronic has recalled 891 implantable cardioverter defibrillators (CRT-D) worldwide due to a rare potential for reduced or absent energy output during defibrillation therapy. Units manufactured with a specific feedthrough component are affected.
3,570 implantable cardioverter defibrillators and cardiac resynchronization defibrillators with a specific feedthrough defect may fail to deliver high-voltage therapy when needed.
Medtronic implantable cardioverter defibrillators with specific feedthrough components may fail to deliver high-voltage therapy during treatment. Affected units are being recalled due to risk of reduced or absent energy output.
Medtronic implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators with specific feedthrough components may fail to deliver adequate high-voltage therapy output.